Prascend®
by Boehringer Ingelheim- Oral tablets for use in horses only
- FDA approved for the control of equine Cushing's disease
- Contains the active ingredient pergolide mesylate
- Requires a veterinarian's prescription
| Catalog # | Description | Price | Qty | Autoship | CART | FAVORITES |
sc-363076Rx | 1 mg tab, 60 count | $190.29 | ||||
sc-516040Rx | 1 mg tab, 160 count | $420.09 |
Click product's Autoship icon - choose frequency at Checkout.
Never forget a shipment so you're always stocked.
Saves you 5% on UltraCruz® products.
You manage the frequency or cancellation to fit your needs.
Prascend® tablets are approved by the FDA for the control of Pituitary Pars Intermedia Dysfunction (Equine Cushing's Disease) in horses.
The active ingredient pergolide mesylate is a potent dopamine receptor agonist believed to exert its therapeutic effect by stimulating dopamine receptors.
Pituitary Pars Intermedia Dysfunction is one of the most common diseases of the endocrine system that can affect horses. PPID causes the horse's pituitary gland, which utilizes hormones to control body functions, to work overtime.
Supplied as a box of 60 or 160, 1 mg oral tablets.
A veterinarian's prescription is required for purchase.
